WAYHELOVÁ, Markéta, Aneta MIKULÁŠOVÁ, Jan SMETANA, Vladimíra VALLOVÁ, Dita BLAŽKOVÁ, Hana FILKOVÁ, Lucie MOUKOVÁ a Petr KUGLÍK. Detection of oncogenic mutations in cervical carcinoma using method "High Resolution Melting" (HRM). Neoplasma. Slovenská akademie vied, roč. 63, č. 5, s. 779-788. ISSN 0028-2685. doi:10.4149/neo_2016_516. 2016.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Detection of oncogenic mutations in cervical carcinoma using method "High Resolution Melting" (HRM).
Autoři WAYHELOVÁ, Markéta (203 Česká republika, domácí), Aneta MIKULÁŠOVÁ (203 Česká republika, domácí), Jan SMETANA (203 Česká republika, domácí), Vladimíra VALLOVÁ (703 Slovensko, domácí), Dita BLAŽKOVÁ (203 Česká republika), Hana FILKOVÁ (203 Česká republika), Lucie MOUKOVÁ (203 Česká republika) a Petr KUGLÍK (203 Česká republika, domácí).
Vydání Neoplasma, Slovenská akademie vied, 2016, 0028-2685.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor Genetika a molekulární biologie
Stát vydavatele Slovensko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.871
Kód RIV RIV/00216224:14310/16:00090707
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.4149/neo_2016_516
UT WoS 000385211400016
Klíčová slova anglicky Sanger sequencing.; cervical carcinoma; high resolution melting; mutation
Štítky AKR, rivok
Změnil Změnila: Ing. Andrea Mikešková, učo 137293. Změněno: 3. 4. 2017 11:54.
Anotace
Oncogenic mutations in proto-oncogenes and tumor suppressor genes represent one of key events in cancerogenesis. In this study, we analysed mutation status in PIK3CA, KRAS and EGFR proto-oncogenes and TP53 tumor suppressor gene in a cohort of twenty-four patients diagnosed with squamous cell carcinoma or adenocarcinoma using the screening method "High Resolution Melting" (HRM). Positive findings were confirmed and identified by Sanger sequencing. Totally, we detected DNA sequence changes in targeted regions in seven patients (7/24, 29.2%). In PIK3CA gene, we found six sequence changes in four patients (4/24, 16.7%) and four of them were confirmed as oncogenic mutations. In KRAS gene, we detected sequence changes in four patients (4/24, 16.7%). Conversely, we identified pathogenic or potentially pathogenic sequence changes neither in EGFR nor TP53 genes. Our results suggest that sequence changes are specific neither for a certain histological subtype, clinical stage nor lymph node involvement and they appear independently on the presence of HPV (human papillomavirus) infection since early clinical stages. We observed the correlation between the presence of DNA sequence changes and hTERC gene amplification, but we did not find a significant relationship between the identified DNA sequence changes and detected copy-number alterations using the technique of array-CGH (array-based comparative genomic hybridization). Regardless our results confirmed an important role of oncogenic mutations in PIK3CA and KRAS genes in the neoplastic transformation process in the cervical carcinoma pathogenesis. Their identification in the early clinical stages should encourage further studies to better understand these mutations and exploit them for more detailed diagnostics.
Návaznosti
EE2.3.20.0183, projekt VaVNázev: Centrum experimentální biomedicíny
VytisknoutZobrazeno: 16. 4. 2024 07:34